Big Move For ASLAN Pharmaceuticals Limited
Wed 27 Nov 19 at 05:40 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) soared at $2.32, representing a gain of 81.3%. The stock appeared on our News Catalysts scanner on Fri 22 Nov 19 at 12:16 PM in the 'RECOMMENDATION' category.
The stock spiked on Fri 22 Nov 19 at $2.98 with a volume of 13M+.
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- Paringa Resources Limited (PNRL:NASDAQ), 266.2%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 81.25%
- BIO-key International, Inc. (BKYI:NASDAQ), 39.75%
- AVX Corporation (AVX:NYSE), 36.37%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 35.71%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 33.87%
- Sequans Communications S.A. (SQNS:NYSE), 28.35%
- GTT Communications, Inc. (GTT:NYSE), 25.66%
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 22.54%
- Zosano Pharma Corporation (ZSAN:NASDAQ), 22.37%